SpectronRx, a leading radiopharmaceutical developer and manufacturer, and RLS (Radioisotope Life Sciences) Inc., the third-largest nuclear medicine pharmacy network in the US, today announced an agreement that will significantly enhance the supply and availability of diagnostic and therapeutic radiopharmaceuticals.
June 7, 2023
· 3 min read